{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:57:24Z","timestamp":1780423044225,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.tips.2012.02.003","type":"journal-article","created":{"date-parts":[[2012,4,4]],"date-time":"2012-04-04T06:16:07Z","timestamp":1333520167000},"page":"233-240","source":"Crossref","is-referenced-by-count":10,"title":["Iminoheterocycle as a druggable motif: BACE1 inhibitors and beyond"],"prefix":"10.1016","volume":"33","author":[{"given":"Zhaoning","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2012.02.003_bib0005","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0065-7743(00)35027-8","article-title":"Privileged structures \u2013 an update","volume":"35","author":"Patchett","year":"2000","journal-title":"Ann. Rep. Med. Chem."},{"key":"10.1016\/j.tips.2012.02.003_bib0010","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.tips.2012.02.003_bib0015","doi-asserted-by":"crossref","unstructured":"Evin, G. et al. (2011) BACE inhibitors as potential drugs for the treatment of Alzheimer's disease: focus on bioavailability. Recent Patents on CNS Drug Discovery 6, 91\u2013106","DOI":"10.2174\/157488911795933938"},{"key":"10.1016\/j.tips.2012.02.003_bib0020","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2174\/156720507781788864","article-title":"Memapsin 2 (beta-secretase) inhibitor drug, between fantasy and reality","volume":"4","author":"Ghosh","year":"2007","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.tips.2012.02.003_bib0025","first-page":"441","article-title":"Peptidomimetic BACE1 inhibitors for treatment of Alzheimer's disease: design and evolution","volume":"45","author":"Ulrich","year":"2010","journal-title":"Methods Princ. Med. Chem."},{"key":"10.1016\/j.tips.2012.02.003_bib0030","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1021\/jm901472u","article-title":"Application of fragment-based NMR screening, X-ray crystallography, structure-based design, and focused chemical library design to identify novel \u03bcM leads for the development of nM BACE-1 (\u03b2-site APP cleaving enzyme 1) inhibitors","volume":"53","author":"Wang","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2012.02.003_bib0035","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1021\/jm0607451","article-title":"Acylguanidines as small-molecule \u03b2-secretase inhibitors","volume":"49","author":"Cole","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2012.02.003_bib0040","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1021\/jm061197u","article-title":"Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of \u03b2-secretase","volume":"50","author":"Congreve","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2012.02.003_bib0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"1996","journal-title":"Adv. Drug. Del. Rev."},{"key":"10.1016\/j.tips.2012.02.003_bib0050","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1021\/jm901408p","article-title":"Discovery of cyclic acylguanidines as highly potent and selective \u03b2-site amyloid cleaving enzyme (BACE) inhibitors: part I \u2013 inhibitor design and validation","volume":"53","author":"Zhu","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2012.02.003_bib0055","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1016\/j.bmcl.2010.06.089","article-title":"Fragment-based discovery and optimization of BACE1 inhibitors","volume":"20","author":"Madden","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.tips.2012.02.003_bib0060","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.bmcl.2010.02.075","article-title":"Novel pyrrolyl 2-aminopyridines as potent and selective human \u03b2-secretase (BACE1) inhibitors","volume":"20","author":"Malamas","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.tips.2012.02.003_bib0065","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1021\/jm070825k","article-title":"Discovery of a novel warhead against \u03b2-secretase through fragment-based lead generation","volume":"50","author":"Geschwindner","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2012.02.003_bib0070","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1021\/jm070829p","article-title":"Application of fragment-based lead generation to the discovery of novel, cyclic amidine \u03b2-secretase inhibitors with nanomolar potency, cellular activity, and high ligand","volume":"50","author":"Edwards","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2012.02.003_bib0085","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.bmcl.2007.11.043","article-title":"Acylguanidine inhibitors of \u03b2-secretase: optimization of the pyrrole ring substituents extending into the S\u20321 substrate binding pocket","volume":"18","author":"Jennings","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.tips.2012.02.003_bib0080","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1016\/j.bmcl.2007.08.010","article-title":"Thiophene substituted acylguanidines as BACE1 inhibitors","volume":"17","author":"Fobare","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.tips.2012.02.003_bib0090","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.bmcl.2007.12.010","article-title":"Acylguanidine inhibitors of \u03b2-secretase: optimization of the pyrrole ring substituents extending into the S1 and S3 substrate binding pockets","volume":"18","author":"Cole","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.tips.2012.02.003_bib0095","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1021\/jm901414e","article-title":"Design and synthesis of 5,5\u2032-disubstituted aminohydantoins as potent and selective human \u03b2-secretase (BACE1) inhibitors","volume":"53","author":"Malamas","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2012.02.003_bib0100","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.bmcl.2009.11.052","article-title":"Discovery and initial optimization of 5,5-disubstituted aminohydantoins as potent \u03b2-secretase (BACE1) inhibitors","volume":"20","author":"Nowak","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.tips.2012.02.003_bib0110","first-page":"169","article-title":"Second-generation approved HIV protease inhibitors for the treatment of HIV\/AIDS","volume":"45","author":"Ghosh","year":"2010","journal-title":"Methods Princ. Med. Chem."},{"key":"10.1016\/j.tips.2012.02.003_bib0115","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1074-5521(00)00134-4","article-title":"Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human rennin","volume":"7","author":"Rahuel","year":"2010","journal-title":"Chem. Biol."},{"key":"10.1016\/j.tips.2012.02.003_bib0120","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nature08726","article-title":"Plasmepsin V licenses Plasmodium proteins for export into the host erythrocyte","volume":"463","author":"Russo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.tips.2012.02.003_bib0125","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1021\/cr00105a006","article-title":"Catalytic mechanisms of enzymic glycosyl transfer","volume":"90","author":"Sinnott","year":"1990","journal-title":"Chem. Rev."},{"key":"10.1016\/j.tips.2012.02.003_bib0130","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nchembio.96","article-title":"A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo","volume":"4","author":"Yuzwa","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tips.2012.02.003_bib0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1152\/ajpendo.90281.2008","article-title":"Cross-talk between GlcNAcyclation and phosphorylation: roles in insulin resistance and glucose toxicity","volume":"295","author":"Copeland","year":"2008","journal-title":"Am. J. Physiol. Endocrinol Metab."},{"key":"10.1016\/j.tips.2012.02.003_bib0140","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1367-5931(00)00135-6","article-title":"Glycosidase mechanisms","volume":"4","author":"Rye","year":"2000","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.tips.2012.02.003_bib0145","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1469-185X.1953.tb01386.x","article-title":"Stereochemistry and the mechanism of enzymic reactions","volume":"28","author":"Koshland","year":"1953","journal-title":"Biol. Rev."},{"key":"10.1016\/j.tips.2012.02.003_bib0150","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1055\/s-0029-1216976","article-title":"Synthesis of glycosyltransferase inhibitors glycosyltransferase","volume":"19","author":"Kajimoto","year":"2009","journal-title":"Synthesis"},{"key":"10.1016\/j.tips.2012.02.003_bib0155","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jmb.2004.02.019","article-title":"Crystallographic study of inhibitors of tRNA-guanine transglycosylase suggests a new structure-based pharmacophore for virtual screening","volume":"338","author":"Brenk","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.tips.2012.02.003_bib0160","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.1002\/anie.200702961","article-title":"Potent inhibitors of tRNA-guanine transglycosylase, an enzyme linked to the pathogenicity of the Shigella bacterium: charge-assisted hydrogen bonding","volume":"46","author":"Hortner","year":"2007","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.tips.2012.02.003_bib0165","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1021\/jm100533p","article-title":"Identification and characterization of acidic mammalian chitinase inhibitors","volume":"53","author":"Cole","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2012.02.003_bib0170","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.chembiol.2010.07.018","article-title":"Natural product \u2013 guided discovery of a fungal chitinase inhibitor","volume":"17","author":"Rush","year":"2010","journal-title":"Chem. Biol."},{"key":"10.1016\/j.tips.2012.02.003_bib0175","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1021\/jm901696w","article-title":"Chemical fragments that hydrogen bond to Asp, Glu, Arg, and his side chains in protein binding sites","volume":"53","author":"Chan","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2012.02.003_bib0180","doi-asserted-by":"crossref","first-page":"14229","DOI":"10.1021\/ja106175q","article-title":"Potent, highly selective, and orally bioavailable gem-difluorinated monocationic inhibitors of neuronal nitric oxide synthase","volume":"132","author":"Xue","year":"2010","journal-title":"J. Am. Chem. Soc."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614712000296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614712000296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T04:29:26Z","timestamp":1543033766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614712000296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0165614712000296"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2012.02.003","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}